The Cooper Companies, Inc. (BMV:COO)
Mexico
· Delayed Price · Currency is MXN 1,425.50
0.00 (0.00%)
At close: Nov 25, 2025
Revenue
Fiscal year is November - October.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | 2013 - 2020 |
|---|---|---|---|---|---|
Period Ending | Oct '25 Oct 31, 2025 | Oct '24 Oct 31, 2024 | Oct '23 Oct 31, 2023 | Oct '22 Oct 31, 2022 | 2013 - 2020 |
| Toric Lens Revenue | - |
Log In |
Log In |
Log In | Upgrade
|
| Multifocal Lens Revenue | - |
Log In |
Log In |
Log In | Upgrade
|
| Toric and Multifocal Revenue | 1.35B |
Log In |
Log In |
Log In | Upgrade
|
| Single-Use Sphere Lens Revenue | - |
Log In |
Log In |
Log In | Upgrade
|
| Non Single-Use Sphere Lens and Other Revenue | - |
Log In |
Log In |
Log In | Upgrade
|
| Sphere, Other Revenue | 1.39B |
Log In |
Log In |
Log In | Upgrade
|
| Total CooperVision Revenue | 2.74B |
Log In |
Log In |
Log In | Upgrade
|
| Office and Surgical Products Revenue | 824.00M |
Log In |
Log In |
Log In | Upgrade
|
| Fertility Revenue | 524.60M |
Log In |
Log In |
Log In | Upgrade
|
| Total CooperSurgical Revenue | 1.35B |
Log In |
Log In |
Log In | Upgrade
|
| Revenue (Other) | -2.74B |
Log In |
Log In |
Log In | Upgrade
|
| Revenue (Total) | 4.09B |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is November - October.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | 2013 - 2020 |
|---|---|---|---|---|---|
Period Ending | Oct '25 Oct 31, 2025 | Oct '24 Oct 31, 2024 | Oct '23 Oct 31, 2023 | Oct '22 Oct 31, 2022 | 2013 - 2020 |
| United States Revenue | 2.05B |
Log In |
Log In |
Log In | Upgrade
|
| Europe Revenue | 1.25B |
Log In |
Log In |
Log In | Upgrade
|
| Rest Of The World Revenue | 785.20M |
Log In |
Log In |
Log In | Upgrade
|
| Revenue (Total) | 4.09B |
Log In |
Log In |
Log In | Upgrade
|
EBIT
Fiscal year is November - October.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | 2013 - 2020 |
|---|---|---|---|---|---|
Period Ending | Oct '25 Oct 31, 2025 | Oct '24 Oct 31, 2024 | Oct '23 Oct 31, 2023 | Oct '22 Oct 31, 2022 | 2013 - 2020 |
| CooperVision Operating Income | 729.60M |
Log In |
Log In |
Log In | Upgrade
|
| CooperSurgical Operating Income | 43.40M |
Log In |
Log In |
Log In | Upgrade
|
| Corporate Operating Income | -90.10M |
Log In |
Log In |
Log In | Upgrade
|
| Operating Income (Total) | 682.90M |
Log In |
Log In |
Log In | Upgrade
|
Key Performance Indicators
Fiscal year is November - October.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | 2013 - 2020 |
|---|---|---|---|---|---|
Period Ending | Oct '25 Oct 31, 2025 | Oct '24 Oct 31, 2024 | Oct '23 Oct 31, 2023 | Oct '22 Oct 31, 2022 | 2013 - 2020 |
| CooperVision - Constant Currency Revenue Growth | 5.00% |
Log In |
Log In |
Log In | Upgrade
|
| CooperSurgical - Constant Currency Revenue Growth | 5.00% |
Log In |
Log In |
Log In | Upgrade
|
| Total Company - Constant Currency Revenue Growth | 5.00% |
Log In |
Log In |
Log In | Upgrade
|
| CooperVision - Organic Revenue Growth | 5.00% |
Log In |
Log In |
Log In | Upgrade
|
| CooperSurgical - Organic Revenue Growth | 3.00% |
Log In |
Log In |
Log In | Upgrade
|
| Total Company - Organic Revenue Growth | 4.00% |
Log In |
Log In |
Log In | Upgrade
|